Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth
The Bristol Myers Squibb Q3 2026 results lift revenue guidance as newer drugs grow 12%. EPS fell on a $1.6 billion charge.
Global Healthcare Leaders Back iKure’s USD 1.8 Million Pre-Series A to Scale Technology-Enabled Primary Healthcare Across India
iKure Techsoft has raised USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC to scale its technology-enabled primary healthcare network across…
Philips Partners With CENT to Advance Preventive Diagnostics and Early Risk Detection in India
Philips has entered a strategic collaboration with Bengaluru-based CENT to deploy AI-enabled MRI technology at preventive health screening centres across India, focusing on early risk detection in neurology, spine, and…
restor3d Launches MyFit Digital Suite to Expand Personalized Orthopaedic Care Beyond the Operating Room
restor3d has introduced MyFit, a new digital patient engagement suite that connects orthopaedic patients, surgeons, and long-term clinical outcomes through automated updates, an interactive portal, and a patient-specific outcomes registry.